Nabity Jensen Investment Management Inc Purchases 50 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Nabity Jensen Investment Management Inc raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,736 shares of the healthcare conglomerate’s stock after purchasing an additional 50 shares during the quarter. UnitedHealth Group accounts for about 1.0% of Nabity Jensen Investment Management Inc’s portfolio, making the stock its 24th largest position. Nabity Jensen Investment Management Inc’s holdings in UnitedHealth Group were worth $1,384,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. State Street Corp boosted its stake in UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after buying an additional 563,554 shares during the period. Geode Capital Management LLC boosted its stake in shares of UnitedHealth Group by 1.6% during the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock worth $11,440,133,000 after purchasing an additional 318,039 shares during the period. Franklin Resources Inc. raised its position in UnitedHealth Group by 2.5% in the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after purchasing an additional 193,800 shares during the period. International Assets Investment Management LLC boosted its position in shares of UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after buying an additional 5,290,025 shares during the period. Finally, Ameriprise Financial Inc. lifted its stake in shares of UnitedHealth Group by 0.6% during the 2nd quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock worth $1,920,039,000 after acquiring an additional 21,149 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

UNH opened at $543.21 on Thursday. The firm’s 50-day moving average price is $554.45 and its 200-day moving average price is $563.12. The company has a market cap of $499.91 billion, a P/E ratio of 35.39, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.56 earnings per share. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.55%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. Stephens lifted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Morgan Stanley lowered their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday. Finally, TD Cowen lifted their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Two investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and three have issued a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $626.79.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.